Skip to main content
Varietly

Treatment format comparison

Compounded vs brand-name GLP-1 programs

Compare the commercial and access characteristics without treating different products as clinically interchangeable.

Brand-name pathway

  • FDA-approved finished drug product
  • Pricing depends heavily on coverage and savings eligibility
  • Supply and prior authorization can affect access

Compounded pathway

  • Availability depends on current law and shortage conditions
  • Cash pricing is often presented as a bundled monthly program
  • Pharmacy identity and sourcing require explicit verification

This page must be reviewed whenever FDA shortage or enforcement guidance changes. It is informational, not a recommendation to substitute one product for another.